TLDR: Moberg Analytics and NXT Humans have partnered to integrate generative AI with advanced brain monitoring, launching the Critical Care Copilot platform. This initiative aims to revolutionize neurocritical care by providing personalized, real-time decision support for brain-injured patients, enhancing clinical interventions and potentially saving lives.
PHILADELPHIA, July 29, 2025 – A significant leap forward in neurocritical care is underway as Moberg Analytics, a leader in multimodal monitoring, and NXT Humans, a specialist in generative AI, announce a strategic partnership. This collaboration is set to deploy cutting-edge generative AI directly at the bedside of brain-injured patients, marking a pivotal moment in transforming patient care. The cornerstone of this partnership is the release of the ‘Critical Care Copilot,’ a precision medicine platform designed to individualize care for critically-ill patients at risk of secondary brain injury.
This innovative platform combines Moberg Analytics’ decades of experience in transforming raw brain data into clinically actionable insights with NXT Humans’ expertise in generative AI. The goal is to empower clinicians with smarter, faster, and more effective decision-making capabilities. Dick Moberg, CEO & Founder of Moberg Analytics, emphasized the significance of this integration, stating, ‘At Moberg Analytics, we’ve spent decades transforming raw brain data into clinically actionable insights at the bedside. By integrating generative AI, we’re advancing the next frontier of precision medicine, delivering tailored, real-time decision support when seconds count. This collaboration accelerates our vision: turning complex neurophysiology into timely, personalized interventions that save lives.’
Andrew Fegley, Co-Founder of NXT Humans, highlighted the critical role of AI in this endeavor: ‘Moberg Analytics has spent years turning intricate brain signals into clear bedside insights; our job at NXT Humans is to layer in AI that flags the right pattern the moment it matters. Together we’re converting mass amounts of neuro-data into clear, lifesaving actions – helping medical teams move from reactive to proactive neurocritical care. If these insights help a care team intervene even a minute sooner, that minute can save a life.’
The development of this transformative technology has been fueled by prior support from the Department of Defense. Moberg Analytics has now opened a seed funding round to accelerate the deployment of the Critical Care Copilot at leading pilot sites globally. This initiative underscores a broader trend in healthcare, where AI-powered systems are increasingly being leveraged for early detection, accurate diagnosis, and personalized treatment plans, revolutionizing patient monitoring and diagnosis through biomedical engineering.
Also Read:
- Mayo Clinic Pioneers Medical AI with NVIDIA Blackwell Supercomputing Deployment
- Cognyte Unveils Advanced AI Co-pilot to Revolutionize Investigative Analytics
The integration of AI in healthcare is ushering in an era of personalized medicine, where vast amounts of patient data, including genetic information, lifestyle factors, and medical history, are analyzed to generate highly individualized treatment plans. This approach has shown remarkable success in improving patient outcomes and reducing adverse effects of treatments. The Critical Care Copilot is poised to be a prime example of how AI can convert complex medical data into actionable insights, enabling medical teams to move from reactive to proactive neurocritical care.
